SCHEDULE OF OUTSTANDING WARRANTS (Details) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Number of warrants, beginning balance | 5,770,262 | 2,546,065 |
| Weighted average exercise price, beginning balance | $ 5.91 | $ 7.46 |
| Number of warrants, beginning balance | 9,876,680 | 5,770,262 |
| Weighted average exercise price, beginning balance | $ 4.91 | $ 5.91 |
| Warrants Granted One [Member] | ||
| Number of warrants, beginning balance | 4,106,418 | 3,263,997 |
| Weighted average exercise price, beginning balance | $ 2.44 | $ 6.00 |
| Expiry Date | Dec. 30, 2025 | Jul. 12, 2024 |
| Warrants Granted Two [Member] | ||
| Number of warrants, beginning balance | 93,938 | |
| Weighted average exercise price, beginning balance | $ 3.99 | |
| Expiry Date | Jul. 28, 2024 | |
| Warrants Exercised One [Member] | ||
| Number of warrants, beginning balance | (133,738) | |
| Weighted average exercise price, beginning balance | $ 4.59 | |
| X | ||||||||||
- Definition Class Of Warrant Or Right Expiry Date. No definition available.
|
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised Weighted Average Exercise Price No definition available.
|
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Weighted Average Exercise Price No definition available.
|
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|